Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 26,560
  • Shares Outstanding, K 88,680
  • Annual Sales, $ 0 K
  • Annual Income, $ -120 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/21/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1600 +93.69%
on 10/22/18
0.4609 -32.76%
on 10/16/18
-0.1346 (-30.28%)
since 10/15/18
3-Month
0.1600 +93.69%
on 10/22/18
0.4609 -32.76%
on 10/16/18
-0.0421 (-11.96%)
since 08/15/18
52-Week
0.0910 +240.55%
on 08/08/18
2.4600 -87.40%
on 12/29/17
-0.1401 (-31.13%)
since 11/15/17

Most Recent Stories

More News
Pivot Pharmaceuticals to Launch Pivot Naturals 1% Oral CBD Solution in European Market

Initial Order of 15,000 Bottles to Be Sold Via Distribution Partner S.T.U. GmbH

PVOTF : 0.3099 (+3.47%)
Knol Resources and Pivot Pharmaceuticals Mutually Terminate Letter of Intent for RTO

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot") and Knol Resources Corp. (TSX-V: NOL.H) ("Knol") today announced that they have mutually agreed to terminate the previously announced...

KNOLF : 0.0500 (-16.67%)
NOL-H.VN : 0.065 (unch)
PVOTF : 0.3099 (+3.47%)
Pivot Monetizes Product Portfolio With Strategic Mexican Pharmaceutical Joint Venture Partner

Market Access To 70,000 Points of Sale in Mexico

PVOTF : 0.3099 (+3.47%)
IIROC Trade Resumption - PVOT

Trading resumes in:

PVOTF : 0.3099 (+3.47%)
IIROC Trade Resumption - PVOT

Trading resumes in:

PVOTF : 0.3099 (+3.47%)
Pivot Pharmaceuticals Inc. to Spin Out Non-U.S. Assets to Unlock Shareholder Value

Knol Resources Corp. signs Letter of Intent with Pivot to Form New Canadian-based Cannabis Company

KNOLF : 0.0500 (-16.67%)
NOL-H.VN : 0.065 (unch)
PVOTF : 0.3099 (+3.47%)
Pivot's U.S. subsidiary, Pivot Naturals LLC, Generates Revenue

Signs Contract Manufacturing and Licensing Agreement With Ananda Acquisitions LLC

PVOTF : 0.3099 (+3.47%)
Pivot Appoints Mr. Jim Natoli to Scientific Advisory Board Formerly R & D Category Director At The Coca-Cola Company

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that Mr. Jim Natoli has been appointed to the Company's Scientific Advisory Board effective...

KO : 49.74 (-0.04%)
PVOTF : 0.3099 (+3.47%)
Pivot Appoints Dr. Joseph Borovsky as Chairman of Board of Directors Formerly Director of R & D of The Mead Corporation

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that Dr. Joseph Borovsky has been appointed as Chairman of the Board of Directors of...

PVOTF : 0.3099 (+3.47%)
PVOT.CN : 0.405 (-1.22%)
Pivot Monetizes "RTIC" Technology And Enters Nevada Cannabis Market With Strategic Partner

Transaction Includes Licensing, Manufacturing, Co-marketing and Distribution Agreements

PVOTF : 0.3099 (+3.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade PVOTF with:

Key Turning Points

2nd Resistance Point 0.3315
1st Resistance Point 0.3207
Last Price 0.3099
1st Support Level 0.2883
2nd Support Level 0.2667

See More

52-Week High 2.4600
Fibonacci 61.8% 1.5550
Fibonacci 50% 1.2755
Fibonacci 38.2% 0.9960
Last Price 0.3099
52-Week Low 0.0910

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar